Status:
COMPLETED
STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Major Depressive Disorder
Alcohol Use Disorder
Eligibility:
All Genders
18-65 years
Brief Summary
The purpose of this study is to determine if having an alcohol use disorder affects recovery from depression, and also whether recovery from depression in patients who have alcohol use disorders is al...
Detailed Description
This is an extension of the multi-site sub-study of the National Institute of Mental Health (NIMH) protocol, Sequenced Treatment Alternatives to Relieve Depression (STAR\*D), which utilized the infras...
Eligibility Criteria
Inclusion
- Males and females aged 18- 75 years
- Meets criteria for Non-psychotic Major Depression
- Signs informed consent and able to comply with study
- Hamilton Depression Scale (HAM-D 17) \>14
- Endorses any drinking items on Short Michigan Alcoholism Screening Test
Exclusion
- Pregnant women and women of childbearing potential who are not using a medically accepted means of contraception.
- Women who are breast feeding
- Patients with suicidal ideation that require hospitalization
- Patients with unstable physical disorders
- Patients with a history of allergy to citalopram or history of non-response to an adequate dose of citalopram in the current episode.
- Patients meeting criteria for the following diagnoses as a primary condition: Schizophrenia, Schizoaffective Disorder, Bipolar I, II, and Not Otherwise Specified, Anorexia nervosa, Bulimia, Obsessive Compulsive Disorder
- Patients abusing substances which require detoxification. American Society for Addiction Medicine standards for detoxification will be used (Level III.7). Patients with substance abuse who are in substance abuse treatment will be eligible.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
674 Patients enrolled
Trial Details
Trial ID
NCT00369746
Start Date
September 1 2006
End Date
February 1 2009
Last Update
May 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032